![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HCV Reinfection in Phase 3 Studies of Sofosbuvir
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Christoph Sarrazin,1 Vasily Isakov,2 Evguenia Svarovskaia,3 Ross Martin,3 Krishna Chodavarapu,3 Charlotte Hedskog,3 Diana Brainard,3 Michael Miller,3 Hongmei Mo,3 Jean-Michel Molina,4 Mark S. Sulkowski5
1J. W. Goethe-University Hospital, Frankfurt am Main, Germany; 2Institute of Nutrition, Moscow, Russia; 3Gilead Sciences, Inc., Foster City, California, USA; 4University of Paris Diderot, Paris, France; 5Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
![EASL1.gif](../images/042915/042915-5/EASL1.gif)
![EASL2.gif](../images/042915/042915-5/EASL2.gif)
![EASL3.gif](../images/042915/042915-5/EASL3.gif)
![EASL4.gif](../images/042915/042915-5/EASL4.gif)
![EASL5.gif](../images/042915/042915-5/EASL5.gif)
![EASL6.gif](../images/042915/042915-5/EASL6.gif)
![EASL7.gif](../images/042915/042915-5/EASL7.gif)
![EASL8.gif](../images/042915/042915-5/EASL8.gif)
![EASL9.gif](../images/042915/042915-5/EASL9.gif)
![EASL10.gif](../images/042915/042915-5/EASL10.gif)
![EASL11.gif](../images/042915/042915-5/EASL11.gif)
![EASL12.gif](../images/042915/042915-5/EASL12.gif)
![EASL13.gif](../images/042915/042915-5/EASL13.gif)
![EASL14.gif](../images/042915/042915-5/EASL14.gif)
![EASL15.gif](../images/042915/042915-5/EASL15.gif)
![EASL16.gif](../images/042915/042915-5/EASL16.gif)
![EASL17.gif](../images/042915/042915-5/EASL17.gif)
![EASL18.gif](../images/042915/042915-5/EASL18.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|